GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,443,000 | +345.9% | 189,392 | +410.5% | 1.13% | +137.7% |
| Q2 2020 | $2,342,000 | -40.1% | 37,099 | -51.6% | 0.48% | -37.7% |
| Q1 2020 | $3,913,000 | -26.9% | 76,596 | +13.8% | 0.76% | +38.3% |
| Q4 2019 | $5,351,000 | +16.9% | 67,315 | -28.7% | 0.55% | +43.1% |
| Q3 2019 | $4,578,000 | -1.6% | 94,363 | +6.7% | 0.38% | -9.8% |
| Q2 2019 | $4,654,000 | +26.7% | 88,478 | +27.5% | 0.43% | +30.2% |
| Q1 2019 | $3,673,000 | +811.4% | 69,388 | +607.5% | 0.33% | +662.8% |
| Q4 2018 | $403,000 | -89.9% | 9,807 | -90.7% | 0.04% | -86.6% |
| Q3 2018 | $3,995,000 | -16.8% | 105,123 | -1.1% | 0.32% | -5.3% |
| Q2 2018 | $4,803,000 | +110.3% | 106,272 | +124.8% | 0.34% | +107.4% |
| Q1 2018 | $2,284,000 | -46.4% | 47,278 | -56.4% | 0.16% | +15.6% |
| Q4 2017 | $4,264,000 | +400.5% | 108,346 | +368.2% | 0.14% | +135.0% |
| Q1 2017 | $852,000 | – | 23,142 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |